Mark Juckett

Mark Juckett, MD, is a Professor of Medicine at the University of Minnesota Medical School, specializing in Hematology, Oncology, and Transplantation. His research focuses on hematopoietic cell transplantation (HCT) outcomes, graft-versus-host disease (GVHD), and biobehavioral interventions for post-transplant recovery.

• Professor of Medicine
• Division of Hematology, Oncology, and Transplantation
• University of Minnesota

Dr. Juckett’s work spans clinical trials (e.g., TRX103 Cell Infusion, CIBMTR WC), quality improvement in transplantation via the Engraft Learning Network, and the intersection of immunogenetic features with machine learning models. He investigates factors like frailty, mental distress, and sleep disruption in HCT patients, alongside pharmacological approaches (e.g., MGTA-117, KOMET-007) for hematologic malignancies.

Recent publications highlight trends in HCT donor selection, GVHD prevention strategies, and biobehavioral mechanisms affecting physical and psychological recovery. His collaborations include the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) and CIBMTR, emphasizing multi-center data-driven solutions.